$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
How long does it take to see the effects of regorafenib treatment?
2026-02-01 22:25:32
Check Details
What does ponatinib do?
2026-02-01 22:25:32
Check Details
What are the indications for ponatinib?
2026-02-01 22:25:32
Check Details
Ponatinib is a first-generation targeted drug
2026-02-01 22:25:32
Check Details
What does ponatinib treat?
2026-02-01 22:25:32
Check Details
How long do sunitinib side effects last?
2026-02-01 22:25:32
Check Details
How many years should you take sunitinib?
2026-02-01 22:25:32
Check Details
Sunitinib is a targeted drug of several generations
2026-02-01 22:25:32
Check Details
Does sunitinib work?
2026-02-01 22:25:32
Check Details
Instructions for OjeMDA (tovorafenib)
2026-02-01 22:25:32
Check Details
What are the precautions for OjeMDA (tovorafenib)?
2026-02-01 22:25:32
Check Details
What medicine is OjeMDA (tovorafenib)?
2026-02-01 22:25:32
Check Details
1
2
...
775
776
777
778
779
780
781
...
10222
10223
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Venetoclax Clinical Guide: Mechanism, Indications, and Originator vs. Generic Comparison
2
Dabrafenib Clinical Guide: Indications, Combination Strategies, and BRAF Inhibitor Comparisons
3
Elagolix Side Effects and Safety Guide
4
Hetrombopag vs. Avatrombopag: Key Differences Between Two Oral TPO-RAs and Safety Considerations
5
Lytenava: The First FDA-Approved Ophthalmic Bevacizumab Formulation
6
FDA Approves Lytenava: First Ophthalmic Bevacizumab for Wet AMD
7
Simtriyo (Centanafadine): World's First NDSRI ADHD Drug Approved by FDA
8
Lipfendra (Enlicitide): The World's First Oral PCSK9 Inhibitor Approved by FDA
9
Orforglipron: The World's First Oral Small-Molecule GLP-1 Receptor Agonist for Weight Management
10
Cabozantinib Capsules: A Multi-Targeted Therapy for Progressive Medullary Thyroid Cancer
11
Lorlatinib: Mechanism, Advantages, and Key Considerations of Third-Generation ALK Inhibitor Therapy in ALK-Positive NSCLC
12
FDA Approves Subcutaneous Isatuximab (Sarclisa) for Multiple Myeloma: A New Administration Option